Antitumor effects of a drug combination targeting glycolysis, glutaminolysis and de novo synthesis of fatty acids

  • Authors:
    • Diana Cervantes-Madrid
    • Alfonso Dueñas-González
  • View Affiliations

  • Published online on: June 24, 2015     https://doi.org/10.3892/or.2015.4077
  • Pages: 1533-1542
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

There is a strong rationale for targeting the metabolic alterations of cancer cells. The most studied of these are the higher rates of glycolysis, glutaminolysis and de novo synthesis of fatty acids (FAs). Despite the availability of pharmacological inhibitors of these pathways, no preclinical studies targeting them simultaneously have been performed. In the present study it was determined whether three key enzymes for glycolysis, glutaminolysis and de novo synthesis of FAs, hexokinase-2, glutaminase and fatty acid synthase, respectively, were overexpressed as compared to primary fibroblasts. In addition, we showed that at clinically relevant concentrations lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat, known inhibitors of the mentioned enzymes, exerted a cell viability inhibitory effect. Genetic downregulation of the three enzymes also reduced cell viability. The three drugs were highly synergistic when administered as a triple combination. Of note, the cytotoxicity of the triple combination was low in primary fibroblasts and was well tolerated when administered into healthy BALB/c mice. The results suggest the feasibility and potential clinical utility of the triple metabolic targeting which merits to be further studied by using either repositioned old drugs or newer, more selective inhibitors.
View Figures
View References

Related Articles

Journal Cover

September-2015
Volume 34 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cervantes-Madrid D and Cervantes-Madrid D: Antitumor effects of a drug combination targeting glycolysis, glutaminolysis and de novo synthesis of fatty acids. Oncol Rep 34: 1533-1542, 2015
APA
Cervantes-Madrid, D., & Cervantes-Madrid, D. (2015). Antitumor effects of a drug combination targeting glycolysis, glutaminolysis and de novo synthesis of fatty acids. Oncology Reports, 34, 1533-1542. https://doi.org/10.3892/or.2015.4077
MLA
Cervantes-Madrid, D., Dueñas-González, A."Antitumor effects of a drug combination targeting glycolysis, glutaminolysis and de novo synthesis of fatty acids". Oncology Reports 34.3 (2015): 1533-1542.
Chicago
Cervantes-Madrid, D., Dueñas-González, A."Antitumor effects of a drug combination targeting glycolysis, glutaminolysis and de novo synthesis of fatty acids". Oncology Reports 34, no. 3 (2015): 1533-1542. https://doi.org/10.3892/or.2015.4077